Smartool Private Space

Monitoring of our Progress

Work Progress

WP1: Clinical imaging data 
65 %
WP2: Patient-specific phenotyping and lab on a chip development 
45 %
WP3: Patient-specific genotyping 
40 %
WP4: Refinement of diagnostic, prognostic and treatment CDSS tools 
50 %
WP5: SMARTool Platform design and integration 
40 %
WP6: Dissemination and exploitation 
48 %
WP7: Project management and coordination 
48 %

SMARTool duration and life

SMARTool activities have started at January, 2016 and it will run for 42 months.